1-2 of 2
Edward A. Copelan
Close
Sort by
Journal Articles

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention

Clinical Trials & Observations
Betty K. Hamilton, Lisa A. Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J. Rotz, Robert M. Dean, Aaron T. Gerds, Deepa Jagadeesh, Claudio Brunstein, Craig S. Sauter, Edward A. Copelan, Navneet S. Majhail
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4505–4513.
https://doi.org/10.1182/bloodadvances.2023010310
Published: 2023
Includes: Supplemental data
Journal Articles

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks, Wael Saber
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2922–2936.
https://doi.org/10.1182/bloodadvances.2018024844
Published: 2018
Includes: Supplemental data